[ATX] YoY Annual Result on 31-Mar-2012 [#FY]

Stock
[ATX] Amplia Therapeutics Limited
Announcement Date
30-Mar-2012
Financial Year
2012
Quarter
31-Mar-2012 [#FY]
Profit Trend
YoY- -33.20%
Quarter Report
ATX's Result
ATX's Financial Summary
View:
Show?
Annual Result
31/03/16 31/03/15 31/03/14 30/06/13 31/03/12 31/03/11 31/03/10 CAGR
Revenue 2,263 30 0 0 0 0 0 -
PBT -7,206 -5,237 -4,495 -3,388 -3,254 -2,443 -4,065 10.00%
Tax -2,263 -162 521 0 0 0 0 -
NP -4,943 -5,237 -4,495 -3,388 -3,254 -2,443 -4,065 3.30%
Tax Rate - - - - - - - -
Total Cost 7,206 5,267 4,495 3,388 3,254 2,443 4,065 10.00%
Ratio Analysis
31/03/16 31/03/15 31/03/14 30/06/13 31/03/12 31/03/11 31/03/10 CAGR
NP Margin -218.40 -17,278.70 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/03/16 31/03/15 31/03/14 30/06/13 31/03/12 31/03/11 31/03/10 CAGR
EPS -0.24 -0.27 -0.34 -0.20 -0.15 -0.12 -0.19 3.96%
EPS Diluted -0.24 -0.27 -0.34 -0.20 -0.15 -0.12 -0.19 3.96%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.